Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire·2025-11-07 12:30
PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter and provided a corporate update. The third quarter of 2025 marked a pivotal period fo ...